Mumbai, India , is rapidly becoming a global hub for high-quality Etoricoxib Active Pharmaceutical Ingredient (API) production. Several reputable companies are based in this Indian city, specializing in the synthesis and supply of Etoricoxib, identifiable by its CAS number 202409-33-4. These organizations boast advanced manufacturing facilities and